Recent analyses have identified GRIN2A as a gene associated with susceptibility to schizophrenia [39, 40], and the GluN2A subunit is also suggested to mediate the antidepressant effects of ketamine [36, 37]. Here, GRIN2A is linked to schizophrenia.